Find Technologies for Licensing
The Problem Glaucoma is one of the leading causes of blindness in the world. It is a slow and progressive disease that can lead to vision loss over a long period of time. Over 60 million people worldwide lives with glaucoma using multiple therapies in order to prevent blindness- and the patients’ number will grow…
Read More
The Problems Drug addiction is a scourge of both developed and less-developed societies. The economic impact of drug addiction includes direct treatment costs as well as lost productivity and crime. Neuropathic pain is a chronic pain condition caused by a primary lesion or dysfunction in the nervous system. It can be a consequence of many different…
Read More
The Problem Color generation is commonly pigmentation related, and its pixel size is limited to a few and up to tens of microns, two orders of magnitude larger than the diffraction limit in the visible range. Colors can also be generated via interference processes in photonic crystals and in plasmonic sub-wavelength structures. Plasmonic color generators…
Read More
The Problem The two major pain points of fully bio-compatible non-toxic carbon-based mechanically hard 4-10 nm-sized nanomaterials (nanodiamonds-NDs) are their high reaction times and their extreme-sized methodologies. These two lead to very difficult surface-functionalizing in a versatile manner for a wide range of full various domains applications. The Solution Our innovation successfully discovered that extremely…
Read More
While 3D printing of polymeric materials is prevalent, metals are indispensable for structural support, heat dissipation, and electrical conductivity. Extensive research to allow additive manufacturing (AM) of metals has resulted in a range of techniques, the most established of them are selective laser melting (SLM), electron beam melting (EBM), and metal inkjet printing. Alas, these…
Read More
The Problem Viral infections continuously take place and pose major public health threats; yet, their prevention and treatment modalities are limited while emerging resistant viruses call for the development of alternative treatments. The Solution We developed a novel approach for the prevention and treatment of infections caused by viruses which attach cells via heparan sulfate binding,…
Read More
All-trans retinoic acid, the most active form of vitamin A, is known to be highly beneficial in dermatology and other biomedical applications. However, all-trans retinoic acid is extremely sensitive when exposed to ultraviolet (UV) light, due to the conjugated double bonds that comprise its chemical structure. Our all-trans retinoic acid is protected from light-dependent degradation, keeping…
Read More
The Problem The presence of microbial contamination of surfaces poses a serious problem from the point of view of health protection. There is a growing market demand to improve effectivity, safety, endurance, and cost of anti-microbial coating. The Solution We propose a novel bio-inspired nanocapsule that can firmly attach to any surface and kill encapsulated bacteria.…
Read More
The Problem Sensors require excessive operation power which results in high cost and complex operation. The Solution Novel nanoscale sensors with ultra-low power consumption The Commercial Benefit Our innovative nanoscale sensors are easy to deploy, consume significantly less power, and is almost entirely disposable Market Potential The nanosensor market is expected to reach a CAGR of 79.83%…
Read MoreLicensing
BIRAD grants exclusive and non-exclusive licenses for the commercialization of BIU-based research findings, both to established companies and to new startup ventures established around University technology.
The licenses are granted for specific patents and/or know-how and are limited to a specific field and/or specific products. Licenses include diligence milestones for the development and sale of products covered by the license – to avoid technology "shelving" – and typically include a combination of the following forms of consideration: royalties, milestone payments, upfront fees, equity and/or annual license fees.
Birad's team is ready to assist you :
Nati Fisher
Dr. Iris Haas
Dr. Assaf Sagiv
